imrecoxib/tramadol (HR18042)
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
June 27, 2025
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
(clinicaltrials.gov)
- P2 | N=110 | Terminated | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | N=180 ➔ 110 | Recruiting ➔ Terminated; The sponsor's R&D strategy is adjusted.
Enrollment change • Trial termination • Pain
June 23, 2025
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.
(clinicaltrials.gov)
- P2 | N=187 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Pain
August 31, 2022
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
(clinicaltrials.gov)
- P2 | N=180 | Recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Pain
July 23, 2022
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
(clinicaltrials.gov)
- P2 | N=180 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P2 trial • Pain
1 to 4
Of
4
Go to page
1